AR117835A1 - Complejo diastereoisomérico enriquecido de gadolinio y de un ligando quelante a base de pcta, y proceso de preparación y purificación del mismo - Google Patents

Complejo diastereoisomérico enriquecido de gadolinio y de un ligando quelante a base de pcta, y proceso de preparación y purificación del mismo

Info

Publication number
AR117835A1
AR117835A1 ARP200100125A ARP200100125A AR117835A1 AR 117835 A1 AR117835 A1 AR 117835A1 AR P200100125 A ARP200100125 A AR P200100125A AR P200100125 A ARP200100125 A AR P200100125A AR 117835 A1 AR117835 A1 AR 117835A1
Authority
AR
Argentina
Prior art keywords
preparation
purification
pcta
binder
same
Prior art date
Application number
ARP200100125A
Other languages
English (en)
Spanish (es)
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Publication of AR117835A1 publication Critical patent/AR117835A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP200100125A 2019-01-17 2020-01-17 Complejo diastereoisomérico enriquecido de gadolinio y de un ligando quelante a base de pcta, y proceso de preparación y purificación del mismo AR117835A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1900432A FR3091873B1 (fr) 2019-01-17 2019-01-17 Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Publications (1)

Publication Number Publication Date
AR117835A1 true AR117835A1 (es) 2021-08-25

Family

ID=67001953

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200100125A AR117835A1 (es) 2019-01-17 2020-01-17 Complejo diastereoisomérico enriquecido de gadolinio y de un ligando quelante a base de pcta, y proceso de preparación y purificación del mismo

Country Status (28)

Country Link
US (3) US11590246B2 (enExample)
EP (2) EP3902800B1 (enExample)
JP (2) JP7071596B2 (enExample)
KR (2) KR102438394B1 (enExample)
CN (3) CN113735854B (enExample)
AR (1) AR117835A1 (enExample)
AU (1) AU2020208794B2 (enExample)
BR (1) BR112021014006B1 (enExample)
CA (1) CA3126268C (enExample)
CL (1) CL2021001868A1 (enExample)
CO (1) CO2021009261A2 (enExample)
DK (2) DK3943493T3 (enExample)
ES (2) ES2930136T3 (enExample)
FI (1) FI3943493T3 (enExample)
FR (1) FR3091873B1 (enExample)
HR (2) HRP20221402T1 (enExample)
HU (2) HUE062554T2 (enExample)
IL (1) IL284884B2 (enExample)
MA (2) MA54626A (enExample)
MX (1) MX2021008651A (enExample)
PH (1) PH12021551725A1 (enExample)
PL (2) PL3902800T3 (enExample)
PT (2) PT3902800T (enExample)
RS (1) RS64334B1 (enExample)
SG (1) SG11202107779SA (enExample)
TW (1) TWI811518B (enExample)
WO (1) WO2020148436A1 (enExample)
ZA (1) ZA202104994B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10973934B2 (en) 2018-08-06 2021-04-13 Bracco Imaging S.P.A. Gadolinium bearing PCTA-based contrast agents
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
US20230339945A1 (en) * 2020-07-17 2023-10-26 Guerbet Method for preparing a chelating ligand derived from pcta
WO2022072947A1 (en) * 2020-10-02 2022-04-07 Eagle Harbor Technologies, Inc. Ion current droop compensation
CN119698423A (zh) * 2022-09-01 2025-03-25 泰瑞诺科有限公司 新型化合物以及包含其的mri造影剂
KR102845061B1 (ko) * 2022-09-01 2025-08-13 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제
WO2026027591A1 (en) 2024-07-31 2026-02-05 Bracco Imaging Spa Synthesis of an intermediate of a gadolinium-based contrast agent

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4001655A1 (de) 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH04154729A (ja) 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
IT1292128B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici
EP0992245A1 (en) 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2891830B1 (fr) * 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) * 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
US8119817B2 (en) * 2009-09-29 2012-02-21 Degussa-Huels Ag Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
EP2786768A1 (en) * 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
CA2909919C (fr) * 2013-04-26 2022-07-12 Guerbet Formulation de produit de contraste et son procede de preparation associe
CN104188957B (zh) * 2014-05-28 2017-04-26 中国中医科学院西苑医院 一种防治再狭窄的药物及其制备和使用方法
SG11201909240SA (en) * 2017-04-28 2019-11-28 Otsuka Pharma Factory Inc Method for manufacturing diastereomer of citric acid derivative
US10973934B2 (en) * 2018-08-06 2021-04-13 Bracco Imaging S.P.A. Gadolinium bearing PCTA-based contrast agents
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese

Also Published As

Publication number Publication date
CN113646308B (zh) 2024-12-13
HUE060343T2 (hu) 2023-02-28
ES2930136T3 (es) 2022-12-07
CA3126268A1 (fr) 2020-07-23
IL284884B2 (en) 2025-09-01
MX2021008651A (es) 2021-10-26
FI3943493T3 (fi) 2023-07-19
PT3943493T (pt) 2023-07-12
IL284884A (en) 2021-08-31
IL284884B1 (en) 2025-05-01
PL3902800T3 (pl) 2022-12-27
ZA202104994B (en) 2023-04-26
JP2022009463A (ja) 2022-01-14
MA55389A (fr) 2022-01-26
US12064487B2 (en) 2024-08-20
US20220062443A1 (en) 2022-03-03
PH12021551725A1 (en) 2022-04-11
EP3943493B1 (fr) 2023-04-19
HRP20221402T1 (hr) 2023-01-06
CN113735854A (zh) 2021-12-03
SG11202107779SA (en) 2021-08-30
FR3091873A1 (fr) 2020-07-24
EP3902800A1 (fr) 2021-11-03
JP7321230B2 (ja) 2023-08-04
AU2020208794B2 (en) 2023-01-12
MA54626A (fr) 2022-04-20
TW202043227A (zh) 2020-12-01
US20230149568A1 (en) 2023-05-18
BR112021014006A2 (pt) 2021-09-21
PL3943493T3 (pl) 2023-08-07
WO2020148436A1 (fr) 2020-07-23
CO2021009261A2 (es) 2021-12-10
BR112021014006B1 (pt) 2023-05-02
CN113646308A (zh) 2021-11-12
TWI811518B (zh) 2023-08-11
JP7071596B2 (ja) 2022-05-19
RS64334B1 (sr) 2023-08-31
CA3126268C (fr) 2024-01-09
AU2020208794A1 (en) 2021-08-05
PT3902800T (pt) 2022-11-16
EP3943493A1 (fr) 2022-01-26
CN119552163A (zh) 2025-03-04
HUE062554T2 (hu) 2023-11-28
US11590246B2 (en) 2023-02-28
KR20210109039A (ko) 2021-09-03
EP3902800B1 (fr) 2022-09-07
US20240358863A1 (en) 2024-10-31
CN113735854B (zh) 2024-05-14
KR102438394B1 (ko) 2022-09-01
HRP20230678T1 (hr) 2023-09-29
FR3091873B1 (fr) 2020-12-25
KR102502862B1 (ko) 2023-02-23
DK3943493T3 (da) 2023-07-24
DK3902800T3 (da) 2022-11-28
CL2021001868A1 (es) 2022-01-21
ES2950118T3 (es) 2023-10-05
JP2022508496A (ja) 2022-01-19
KR20210138134A (ko) 2021-11-18

Similar Documents

Publication Publication Date Title
CO2021009261A2 (es) Complejo de gadolinio y un ligando quelatante derivado de pcta diastereoisoméricamente enriquecido y método de preparación y de purificación
CL2024000373A1 (es) Compuesto inductor de la degradación de plk1 novedoso
PE20220134A1 (es) Compuestos de pirrolidina
MX2020013853A (es) Compuestos innovadores.
CO2021009253A2 (es) Complejo de gadolinio y un ligando quelatante derivado de pcta diastereoisoméricamente enriquecido y método de síntesis
CO2019011604A2 (es) Compuestos inhibidores de vmat2, composiciones y métodos relativos a los mismos
CU24265B1 (es) Compuestos derivados de benzamida para inhibir la actividad de abl1, abl2 y bcr-abl1, útiles en el tratamiento del cáncer
MX2017010062A (es) [9,10-dimetoxi-3-(2-metilpropil)-1h,2h,3h,4h,6h,7h,11bh-pirido-[2 ,1-a]isoquinolin-2-il]metanol y compuestos, composiciones y metodos relacionados con los mismos.
AR093244A1 (es) Compuestos de benceno sustituidos utilizables en el tratamiento de trastornos mediados por ezh2
UY39197A (es) Mezclas y composiciones que comprenden 5-fluoro-4-imino-3- metil-1-tosil-3,4-dihidropirimidin-2-ona, y métodos de uso de las mismas
CL2021002263A1 (es) Compuestos antibacterianos (solicitud divisional 202001147)
MX380751B (es) Ingrediente perfumante verde de lirio del valle.
AR123424A1 (es) Nuevos compuestos heterocíclicos
ECSP21088111A (es) Analogos de 3–(5–metil–1,3–tiazol–2–il)–n–{(1r)–1–[2–(trifluor–metil)pirimidin–5–il]etil}benzamida
AR104731A1 (es) Benzamidas sustituidas y métodos para utilizarlas
MX2020004930A (es) Compuestos de biarilo sustituido novedosos como inhibidores de indolamina 2,3-dioxigenasa (ido).
UY38941A (es) Nuevas sulfiliminas o sulfoximinas que contienen compuestos heterocíclicos fungicidas
CL2023003921A1 (es) Inhibidores de transglutaminasas
ECSP21011232A (es) Nuevo derivado de amina heterocíclico y composición farmacéutica que lo comprende
MX2020012829A (es) Compuestos de ciclopentanona.
MX2022002941A (es) Cristal de derivado de 1,3,5-triazina o solvato del mismo y metodo para producir el mismo.
MX2021012544A (es) Compuestos novedosos y composiciones farmaceuticas de los mismos para el tratamiento de enfermedades renales.
MX2023015490A (es) Inhibidores de las transglutaminasas.
AR106516A1 (es) PROCESO PARA LA PREPARACIÓN DE 17b-HIDROXI-DES-A-ANDROST-9,10-EN-5-ONA
ECSP24007534A (es) Inhibidores de transglutaminasas